Page 3 - சிறப்பு அதிகாரம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சிறப்பு அதிகாரம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சிறப்பு அதிகாரம் Today - Breaking & Trending Today

Decision to fund treatments for rare metabolic disorders

Decision to fund treatments for rare metabolic disorders
12 April 2021
Decision
We are pleased to announce a decision to fund six treatments for people with rare metabolic disorders.
What we’re doing
We are pleased to announce a decision to fund six treatments for people with rare metabolic disorders. The following treatments will be listed on the Pharmaceutical Schedule from 1 May 2021:
Carglumic acid for acute inpatient treatment of hyperammonaemia arising from severe organic acidaemia as an alternative to haemofiltration.
Various supplements for inborn errors of metabolism:
Coenzyme Q10 for treatment of inborn errors of metabolism responsive to coenzyme Q10 supplementation.
Levocarnitine for treatment of inborn errors of metabolism responsive carnitine supplementation. ....

Special Authority , சிறப்பு அதிகாரம் ,

Decision to widen access to secukinumab for psoriatic arthritis and ankylosing spondylitis

From 1 May 2021 more people will be able to access secukinumab sooner. ....

Special Authority , சிறப்பு அதிகாரம் ,

Cilazapril: No new patients from 1 May 2021

Find out what this means for you. ....

Special Authority , சிறப்பு அதிகாரம் ,

New Zealand Expands Patient Access to Funded MS Treatments

PHARMAC, the government health agency of New Zealand, will expand patient access to a list of funded treatments for multiple sclerosis, starting on March 1. ....

New Zealand , Amanda Rose , Lisa Williams , Leiden University Medical Center , Sclerosis Treatment Assessment Committee , Sclerosis Society Of New Zealand , Biomedical Sciences , Expanded Disability Status Scale , Jeremy Seed , Multiple Sclerosis Treatment Assessment , Special Authority , Multiple Sclerosis Society , Developmental Biology , Universidade De Lisboa , Medical Microbiology , Infectious Diseases , Applied Biology , Instituto De Medicina Molecular , புதியது ஜீலாந்து , அமண்டா உயர்ந்தது , லிசா வில்லியம்ஸ் , ஸ்க்லரோசிஸ் சிகிச்சை மதிப்பீடு குழு , ஸ்க்லரோசிஸ் சமூகம் ஆஃப் புதியது ஜீலாந்து , உயிர் மருத்துவ அறிவியல் , விரிவாக்கப்பட்டது இயலாமை நிலை அளவு , ஜெர்மி விதை ,

PHARMAC widens access to funded treatments for multiple sclerosis

PHARMAC widens access to funded treatments for multiple sclerosis
12 February 2021
Media release
Medicines
PHARMAC announced today that it will be widening access to all funded multiple sclerosis treatments from 1 March. 1800 people with multiple sclerosis will be able to stay on their treatment for longer, and some who had stopped funded treatment may now be eligible to restart.
Multiple sclerosis is a progressive neurological condition that leads to increasing levels of disability. Jeremy Seed (Kai Tahu/ Kati Mamoe) has had multiple sclerosis for eleven years. The former New Zealand Army officer and father of two is relieved that he will be able to stay on his treatment for longer. “It is really good news. The 500 metre walk was an annual stressor, and I was worried each time I would no longer qualify for my medication. Ironically, stress can exacerbate MS, so not having to worry about it is fantastic,” says Jeremy. ....

New Zealand , Kai Tahu Kati Mamoe , Amanda Rose , Lisa Williams , Services Association , Zealand Army , Sclerosis Nz National , Kati Mamoe , New Zealand Army , Expanded Disability Status Scale , Special Authority , Sclerosis New Zealand , Multiple Sclerosis , Returning Services Association , புதியது ஜீலாந்து , அமண்டா உயர்ந்தது , லிசா வில்லியம்ஸ் , சேவைகள் சங்கம் , ஜீலாந்து இராணுவம் , ஸ்க்லரோசிஸ் ந்ஸ் தேசிய , புதியது ஜீலாந்து இராணுவம் , விரிவாக்கப்பட்டது இயலாமை நிலை அளவு , சிறப்பு அதிகாரம் , ஸ்க்லரோசிஸ் புதியது ஜீலாந்து , பல ஸ்க்லரோசிஸ் , திரும்பும் சேவைகள் சங்கம் ,